GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Brooks Laboratories (BOM:533543) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 23, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Brooks Laboratories  (BOM:533543) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Brooks Laboratories Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Brooks Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BOM:530163 BOM:526953 BOM:541400 BOM:543998 NSE:ACCENTMIC BOM:524731 BOM:532039 BOM:540937 BOM:524075 BOM:532305 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
BROOKS:India
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Website
https://www.brookslabs.net
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines